The health care products company is scheduled to report second-quarter earnings on April 27. Analysts, on average, expect earnings of $1.03 a share on revenue of $2.89 billion."With several compelling newer products on the market across the medical device portfolio (LigaSure small jaw, Endo GIA with Tri‐Staple technology, Everflex with an SFA indication, Pipeline, and Solitaire), the Newport acquisition should clear headwinds facing Covidien's key medical device business this year," William Blair analysts wrote in a March 23 report. "We anticipate the company will generate mid‐ to high‐single‐digit revenue growth from this unit (on a constant‐currency basis) over the next two years." Forward Annual Dividend Yield: 1.7% Rated "A (Buy)" by TheStreet Ratings: The company's first-quarter gross profit margin was about the same as it was last year. Covidien has average liquidity. Its Quick Ratio is 1.47, which shows the company can technically meet its short-term cash needs. In the first quarter, stockholders' net worth increased 9.95% from the prior year. TheStreet Ratings' price target is $61.92. The stock closed Thursday at $53.93 and has risen 19.82% year to date.
Comcast The media giant is scheduled to report first-quarter earnings on May 1. Analysts, on average, anticipate earnings of 42 cents a share on $14.43 billion in revenue. "Upon review, it appeared as if ARPU growth had been too meager and margins too flat for the core residential business in our prior model, with too-aggressive Business Services margin expansion (however, we do still see a 5-year +30% revenue
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV